首页> 外文期刊>Journal of Nanjing Medical University >Abnormal expression of vascular endothelial growth factor (VEGF) and its clinical features in tissues of human lung cancer
【24h】

Abnormal expression of vascular endothelial growth factor (VEGF) and its clinical features in tissues of human lung cancer

机译:血管内皮生长因子(VEGF)在人肺癌组织中的异常表达及其临床特征

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: Angiogennesis, the formation of new blood vessels from the existing vascular bed, is essential step for growth and invasion of primary tumor. Vascular endothelial growth factor (VEGF) is known to play crucial role in tumor angiogenesis. In the present study, we investigate the expression of VEGF and VEGF-mRNA in the angiogennesis, metastasis and prognosis of lung cancer. Methods: The VEGF cellular distributions and expression in 38 specimens of patients with lung cancer were investigated with immunohistochemistry stain technology. The total RNAs in 38 tissues of lung cancer was measured, then the levels of VEGF-mRNA expression were analyzed by a reverse-transcription polymerase chain reaction (RT-PCR) assay. The levels of VEGF in sera of patients with lung cancer, benign lung diseases and healthy controls were detected through Enzyme linked immunosorbent assay (ELISA) method. Results: The VEGF positive stain was 76% in 38 cases of lung cancer specimens. The 89% rate of VEGF stain was found for clinical stage Ⅲ cases and 92% for stage Ⅳ lung cancers. The significantly higher expression of VEGF was evidenced in patients with lymph node metastasis (84 %), distant metastasis (90%), and lung cancers with lower histological differentiation (89%), respectively. The expression level of total RNA was significantly higher in patients with lung cancers than that in their paracancerous or distant lung tissues. The VEGF expressions were tightly correlated with total RNA concentration of lung carcinoma ( P < 0.01). The predominant expressions of VEGF121 and VEGF165 gene fragments were found in lung cancer specimens by RT-PCR analysis. No significant difference of serum VEGF levels was detected between cases with lung cancer and patients with benign diseases. However, the VEGF level of cases with benign diseases was decreased significantly after patients with anti-inflammation medication. Conclusion: The present data suggested that the tumor tissue VEGF expression and VEGF-mRNA analysis in patients with lung cancer be a useful indicator for angiogenesis and metastasis of lung cancer.
机译:目的:血管生成术是从现有血管床形成新血管,是原发性肿瘤生长和侵袭的重要步骤。已知血管内皮生长因子(VEGF)在肿瘤血管生成中起关键作用。在本研究中,我们研究了VEGF和VEGF-mRNA在肺癌血管生成,转移和预后中的表达。方法:采用免疫组织化学染色技术检测38例肺癌患者的VEGF细胞分布及表达。测量了38个肺癌组织的总RNA,然后通过逆转录聚合酶链反应(RT-PCR)分析了VEGF-mRNA的表达水平。通过酶联免疫吸附法(ELISA)检测肺癌,良性肺部疾病和健康对照者血清中的VEGF水平。结果:38例肺癌标本中VEGF阳性染色率为76%。 Ⅲ期临床发现VEGF染色率为89%,Ⅳ期肺癌为92%。在淋巴结转移(84%),远处转移(90%)和组织学分化程度较低(89%)的肺癌患者中,VEGF的表达明显较高。肺癌患者的总RNA表达水平明显高于癌旁或远处的肺组织。 VEGF的表达与肺癌总RNA浓度密切相关(P <0.01)。通过RT-PCR分析发现在肺癌标本中VEGF121和VEGF165基因片段的主要表达。在肺癌患者和良性疾病患者之间未发现血清VEGF水平有显着差异。然而,使用抗炎药后,良性疾病患者的VEGF水平显着降低。结论:目前的数据表明,肺癌患者肿瘤组织VEGF的表达和VEGF-mRNA的分析可作为肺癌血管生成和转移的有用指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号